Vivos Inc (RDGL)

[SC8]

In context of this market, useful IP means patent barriers to entry to keep out generics. Trademarks don't stop generics. Nor can a weak process patent stop generics, and that's all RDGL has. Only way RDGL can keep out generics is to price Radiogel low enough it's not worth to enter market. That lack of pricing power in turn greatly reduces any buyout price. That's what happens when patents expire. It is what it is.